Literature DB >> 1342217

Mechanisms underlying the genesis of post-rest contractions in cardiac muscle.

J G Mill1, D V Vassallo, C M Leite.   

Abstract

1. Post-rest potentiation reflects basic cellular mechanisms that control cardiac muscle contraction. Transmembrane calcium influx, the Na+/Ca2+ exchange and the function of intracellular stores that liberate activator calcium upon activation are some of the mechanisms involved. 2. Three aspects of the post-rest potentiated phenomenon were investigated, using isometrically contracting rat papillary muscles and toad ventricle strips: dependence on 1) inotropic state of steady-state contractions, 2) pause duration and Na+/Ca2+ exchange activity, and 3) the extent of transmembrane calcium influx. 3. The results suggest that the potentiated state of post-rest contractions increases linearly with the inotropic state of preceding steady-state control contractions. As the pause duration increases from 5 to 240 s, the post-rest potentiation also increases, attaining a steady level after 30-s pauses. During the pause, the Na+/Ca2+ exchange mechanism operates at an activity level that can alter the amount of activator calcium used for post-rest contractions. Interventions that increase intracellular Na+, such as the increase of the stimulation rate from 0.5 to 1 Hz or the increase of extracellular NaCl concentration to 160 mM, reduce the Na+/Ca2+ activity, increasing intracellular Ca2+ and post-rest potentiation. The decrease of transmembrane Ca2+ influx during activation increases the relative participation of the sarcoplasmic reticulum in the development of post-rest potentiation. Reduction of extracellular Ca2+ concentration from 1.25 mM to 0.25 mM or the use of 1 microM verapamil and 2 mM manganese increases the relative potentiation of post-rest contractions. This is particularly observed in toad ventricle strips since post-rest potentiation, which does not develop under control conditions, is observed after verapamil or manganese treatment. The results suggest that the excitation-contraction coupling process operating for post-rest contraction activation, unlike that operating for steady-state contraction activation, depends more on the calcium stored at intracellular sites than on transmembrane calcium influx.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1342217

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  5 in total

1.  The new compound, LASSBio 294, increases the contractility of intact and saponin-skinned cardiac muscle from Wistar rats.

Authors:  R T Sudo; G Zapata-Sudo; E J Barreiro
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  Cardiovascular adaptive responses in rats submitted to moderate resistance training.

Authors:  Rita de Cássia Cypriano Ervati Pinter; Alessandra Simão Padilha; Edilamar Menezes de Oliveira; Dalton Valentim Vassallo; Juliana Hott de Fúcio Lizardo
Journal:  Eur J Appl Physiol       Date:  2008-05-10       Impact factor: 3.078

3.  Calcium-antagonizing activity of S-petasin, a hypotensive sesquiterpene from Petasites formosanus, on inotropic and chronotropic responses in isolated rat atria and cardiac myocytes.

Authors:  Guei-Jane Wang; Jyh-Fei Liao; Kadon K Hintz; Wen-Pin Chen; Ming-Jai Su; Yun-Lian Lin; Chuen-Chao Shi; Chieh-Fu Chen; Jun Ren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-04       Impact factor: 3.000

4.  A single resistance exercise session improves myocardial contractility in spontaneously hypertensive rats.

Authors:  A A Fernandes; T de O Faria; R F Ribeiro Júnior; G P Costa; B Marchezini; E A Silveira; J K Angeli; I Stefanon; D V Vassallo; J H Lizardo
Journal:  Braz J Med Biol Res       Date:  2015-07-10       Impact factor: 2.590

5.  Acute exposure to lead increases myocardial contractility independent of hypertension development.

Authors:  M Fioresi; L B Furieri; M R Simões; R F Ribeiro; E F Meira; A A Fernandes; I Stefanon; D V Vassallo
Journal:  Braz J Med Biol Res       Date:  2013-02-01       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.